Abstract
In this paper I address the conflict of interest (CoI) issue from a legal point of view at a European level. We will see that the regulatory framework that exists in Europe does state the need for the independence of ethics committee involved in authorisation of research and clinical trials. We will see that CoI is an element that has to be closely monitored at National and International level. Therefore, Member States and Newly Associated States do have to address CoI in the authorisation process of research and clinical protocols of biomedicine.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
Author information
Authors and Affiliations
Corresponding author
Additional information
The opinions here expressed are personal and do not commit the European Commission.
An earlier version of this paper was delivered at a Conference on Conflict of Interest and Its Significance in Science and Medicine, 5–6 April, 2002, Warsaw, Poland.
The author is a Scientific Officer in the Programme Science and Society dealing with ethics and science (Unit C.3).
Rights and permissions
About this article
Cite this article
Salvi, M. Conflict of interest in biomedical research: a view from Europe. SCI ENG ETHICS 9, 101–108 (2003). https://doi.org/10.1007/s11948-003-0023-z
Issue Date:
DOI: https://doi.org/10.1007/s11948-003-0023-z